201 related articles for article (PubMed ID: 17919837)
1. Planning target margin calculations for prostate radiotherapy based on intrafraction and interfraction motion using four localization methods.
Beltran C; Herman MG; Davis BJ
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):289-95. PubMed ID: 17919837
[TBL] [Abstract][Full Text] [Related]
2. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging.
Schallenkamp JM; Herman MG; Kruse JJ; Pisansky TM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):800-11. PubMed ID: 16199313
[TBL] [Abstract][Full Text] [Related]
3. Measurements of intrafraction motion and interfraction and intrafraction rotation of prostate by three-dimensional analysis of daily portal imaging with radiopaque markers.
Aubry JF; Beaulieu L; Girouard LM; Aubin S; Tremblay D; Laverdière J; Vigneault E
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):30-9. PubMed ID: 15337537
[TBL] [Abstract][Full Text] [Related]
4. A randomized comparison of interfraction and intrafraction prostate motion with and without abdominal compression.
Rosewall T; Chung P; Bayley A; Lockwood G; Alasti H; Bristow R; Kong V; Milosevic M; Catton C
Radiother Oncol; 2008 Jul; 88(1):88-94. PubMed ID: 18279985
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric consequences of intrafraction prostate motion.
Li HS; Chetty IJ; Enke CA; Foster RD; Willoughby TR; Kupellian PA; Solberg TD
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):801-12. PubMed ID: 18234439
[TBL] [Abstract][Full Text] [Related]
6. Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers.
Kotte AN; Hofman P; Lagendijk JJ; van Vulpen M; van der Heide UA
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):419-25. PubMed ID: 17513059
[TBL] [Abstract][Full Text] [Related]
7. Optimal planning target margin for prostate radiotherapy based on interfractional and intrafractional variability assessment during 1.5T MRI-guided radiotherapy.
Kim J; Sung J; Lee SJ; Cho KS; Chung BH; Yang D; Kim J; Kim JW
Front Oncol; 2023; 13():1337626. PubMed ID: 38173837
[TBL] [Abstract][Full Text] [Related]
8. Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer.
Hoogeman MS; van Herk M; de Bois J; Lebesque JV
Radiother Oncol; 2005 Feb; 74(2):177-85. PubMed ID: 15734206
[TBL] [Abstract][Full Text] [Related]
9. Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion.
Tanyi JA; He T; Summers PA; Mburu RG; Kato CM; Rhodes SM; Hung AY; Fuss M
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1579-85. PubMed ID: 20472357
[TBL] [Abstract][Full Text] [Related]
10. Clinical application of a repositioning scheme, using gold markers and electronic portal imaging.
Van den Heuvel F; Fugazzi J; Seppi E; Forman JD
Radiother Oncol; 2006 Apr; 79(1):94-100. PubMed ID: 16581149
[TBL] [Abstract][Full Text] [Related]
11. An endorectal balloon reduces intrafraction prostate motion during radiotherapy.
Smeenk RJ; Louwe RJ; Langen KM; Shah AP; Kupelian PA; van Lin EN; Kaanders JH
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):661-9. PubMed ID: 22099035
[TBL] [Abstract][Full Text] [Related]
12. Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy.
Schiffner DC; Gottschalk AR; Lometti M; Aubin M; Pouliot J; Speight J; Hsu IC; Shinohara K; Roach M
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):610-9. PubMed ID: 17236978
[TBL] [Abstract][Full Text] [Related]
13. Set-up errors due to endorectal balloon positioning in intensity modulated radiation therapy for prostate cancer.
Wang CW; Chong FC; Lai MK; Pu YS; Wu JK; Cheng JC
Radiother Oncol; 2007 Aug; 84(2):177-84. PubMed ID: 17706309
[TBL] [Abstract][Full Text] [Related]
14. Prostate planning treatment volume margin calculation based on the ExacTrac X-Ray 6D image-guided system: margins for various clinical implementations.
Alonso-Arrizabalaga S; Brualla González L; Roselló Ferrando JV; Pastor Peidro J; López Torrecilla J; Planes Meseguer D; García Hernández T
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):936-43. PubMed ID: 17889275
[TBL] [Abstract][Full Text] [Related]
15. Day-to-day reproducibility of prostate intrafraction motion assessed by multiple kV and MV imaging of implanted markers during treatment.
Mutanga TF; de Boer HC; Rajan V; Dirkx ML; Incrocci L; Heijmen BJ
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):400-7. PubMed ID: 22019244
[TBL] [Abstract][Full Text] [Related]
16. Image-guided radiotherapy with implanted markers and kilovoltage imaging and 6-dimensional position corrections for intrafractional motion of the prostate.
Badakhshi H; Wust P; Budach V; Graf R
Anticancer Res; 2013 Sep; 33(9):4117-21. PubMed ID: 24023358
[TBL] [Abstract][Full Text] [Related]
17. Relationship of imaging frequency and planning margin to account for intrafraction prostate motion: analysis based on real-time monitoring data.
Curtis W; Khan M; Magnelli A; Stephans K; Tendulkar R; Xia P
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):700-6. PubMed ID: 22795802
[TBL] [Abstract][Full Text] [Related]
18. A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers.
Nichol AM; Brock KK; Lockwood GA; Moseley DJ; Rosewall T; Warde PR; Catton CN; Jaffray DA
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):48-56. PubMed ID: 17084546
[TBL] [Abstract][Full Text] [Related]
19. CTV to PTV margins for prostate irradiation. Three-dimensional quantitative assessment of interfraction uncertainties using portal imaging and serial CT scans.
Pérez-Romasanta LA; Lozano-Martín E; Velasco-Jiménez J; Mendicote-León F; Sanz-Martín M; Torres-Donaire J; Carrascosa-Fernández C; Zapata-Jimínez JC; Arjona-Gutiérrez J; Gil-Agudo A
Clin Transl Oncol; 2009 Sep; 11(9):615-21. PubMed ID: 19776002
[TBL] [Abstract][Full Text] [Related]
20. Daily online localization using implanted fiducial markers and its impact on planning target volume for carcinoma prostate.
Khosa R; Nangia S; Chufal KS; Ghosh D; Kaul R; Sharma L
J Cancer Res Ther; 2010; 6(2):172-8. PubMed ID: 20622364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
